NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Sunday, June 15, 2008  
Online Pharmacy - Bentley Board Approves Spin-off Of Drug Delivery Business
Bentley Board Approves Spin-off Of Drug Delivery Business
The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) approved the spin-off of its drug delivery business into a new publicly traded company to be called CPEX Pharmaceuticals, Inc. CPEX is a drug delivery company involved in the business of development, licensing and commercialization of pharmaceutical products utilizing validated drug delivery technology.
Source: www.medicalnewstoday.com

Treating Pain Effectively - New Study Results Confirm Improved Gastrointestinal Tolerability Of Tapentadol
Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal tolerability(1) as well as safety(2) profile compared to oxycodone HCl IR. The data were presented by the German pharmaceutical company Grunenthal at this year's Annual Congress of the European League against Rheumatism (EULAR, June 11-14, Paris, France).
Source: www.medicalnewstoday.com

Array BioPharma Presents Additional Positive Phase 1 Results In Two Programs At The 2008 Annual European Congress Of Rheumatology
Array BioPharma Inc. (Nasdaq: ARRY) announced that its Chief Medical Officer, John Yates, M.D., presented additional positive results from a Phase 1 clinical trial evaluating the pharmacokinetic and pharmacodynamic activity of ARRY-162, a novel small molecule MEK inhibitor, at the 2008 Annual European Congress of Rheumatology (EULAR) in Paris, France.
Source: www.medicalnewstoday.com

'B Me' Unveils Novel Design Concepts Reflecting The Needs Of Individuals With Rheumatoid Arthritis
A unique condom packet. A fashionable wrist splint. Clothing with innovative fasteners. These are just a few examples of design concepts unveiled today as part of the 'B Me' initiative, on display at the annual European League Against Rheumatism (EULAR) congress in Paris. 'B Me' is an international awareness initiative that puts the spotlight on rheumatoid arthritis by using design concepts to challenge the way people think about living with this condition.
Source: www.medicalnewstoday.com

Labels: ,


Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.